[October 24, 2017] |
|
Hemoglobinuria Global Clinical Trials Review - H2, 2017 - Research and Markets
The "Hemoglobinuria
Global Clinical Trials Review, H2, 2017" clinical trials has
been added to Research and Markets' offering.
The clinical trial report provides an overview of Hemoglobinuria
clinical trials scenario. This report provides top line data relating to
the clinical trials on Hemoglobinuria. It includes an overview of trial
numbers and their average enrollment in top countries conducted across
the globe. The report offers coverage of disease clinical trials by
region, country (G7 & E7), phase, trial status, end points status and
sponsor type. Report also provides prominent drugs for in-progress
trials (based on number of ongoing trials).
The report enhances the decision making capabilities and helps to create
an effective counter strategies to gain competitive advantage.
Scope of the Report:
-
The report provides a snapshot of the global clinical trials landscape
-
Report provides top level data related to the clinical trials by
Region, Country (G7 & E7) Trial Status, Trial Phase, Sponsor Type and
End point status
-
The report reviews top companies involved and enlists all trials
(Trial title, Phase, and Status) pertaining to the company
-
The report provides all the unaccomplished trials (Terminated,
Suspended and Withdrawn) with reason for unaccomplishment
-
The Report provides enrollment trends for the past five years
-
Report provides latest news for the past three months
Reasons to Buy:
-
Assists in formulating key business strategies with regards to
investment
-
Helps in identifying prominent locations for conducting clinical
trials which saves time and cost
-
Provides top level analysis of Global Clinical Trials Market which
helps in identifying key business opportunities
-
Supports understanding of trials count and enrollment trends by
country in global therapeutics market
-
Aids in interpreting the success rates of clinical trials by providing
a comparative scenario of completed and uncompleted (terminated,
suspended or withdrawn) trials
-
Facilitates clinical trial assessment of the indication on a global,
regional and country level
Companies Mentioned
-
Alexion Pharmaceuticals Inc
-
Clinical Network Services (CNS) Pty Ltd
-
Apellis Pharmaceuticals Inc
-
Achillion Pharmaceuticals Inc
-
Akari Therapeutics Plc
-
Alnylam Pharmaceuticals Inc
-
Ra Pharmaceuticals Inc
-
CMIC Holdings Co Ltd
-
Amgen Inc
For more information about this clinical trials report visit https://www.researchandmarkets.com/research/h36m9l/hemoglobinuria
View source version on businesswire.com: http://www.businesswire.com/news/home/20171024005808/en/
[ Back To TMCnet.com's Homepage ]
|